Synthesis, Characterization, and Biological Evaluation of Novel Nitrogen-Containing Heterocyclic Compounds

Nitrogen-containing heterocycles constitute a central structural class in medicinal chemistry, and 1,2,4-triazole derivatives remain attractive because of their synthetic accessibility, electronic versatility, and recurrent antibacterial and antifungal activity. This study presents a coherent design for a series of ten Schiff-base 1,2,4-triazole derivatives (T1–T10) obtained by condensation of a 4-amino-5-aryl-4H-1,2,4-triazole-3-thiol intermediate with substituted benzaldehydes. The compounds were characterized through melting-point determination, FTIR, ¹H NMR, ¹³C NMR, and mass spectrometry. Antimicrobial performance was evaluated against representative Gram-positive and Gram-negative bacteria and two fungal strains using broth microdilution, with ciprofloxacin and fluconazole as reference drugs. The experimental data reveals a substituent dependence, with the halogenated (especially T6 and T10) derivatives exhibiting the lowest inhibition concentrations and the unsubstituted and weakly e-donating analogues being less active. Spectroscopic data are indicative of the formation of Schiff-base and retention of the triazole-thiol pharmacophore. Further exploratory SAA suggests electronic effects and lipophilicity, as factors, are not mutually exclusive, but work in combination to determine the biological response. As such the study offers an experimental platform for testing and development of nitrogen containing heterocycles as antimicrobial leads and for prospective optimization of the physicochemical parameters.